Clinical Study for Cell-cultured Influenza Vaccine

Multicenter, Open-Label Efficacy and Safety Study of CH7-GD in Healthy Volunteers

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031200112

Enrollment

Registered

2020-09-10

Start date

2020-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza A(H7N9) Influenza A(H7N9), Vaccine

Interventions

Vaccine muscle injection (2 times, 3 weeks apart)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy Volunteers

Exclusion criteria

Exclusion criteria: History of influenza A(H7) infection

Design outcomes

Primary

Measure	Time frame
Antibody titer	—

Secondary

Measure	Time frame
Side Effect and Adverse Reaction	—

Contacts

Public ContactMasahiro Hirata

Shonan Kamakura General Hospital

m_hirata@shonankamakura.or.jp+81-467-46-1717

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026